Wanbangde Pharmaceutical Holding Group Co Ltd operates in the Metals service centers and offices sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Wanbangde Pharmaceutical Holding Group Co Ltd with three other
companies in this sector in CHINA :
Guangdong Jingyi Metal Co Ltd
sales of 5.13 billion Chinese Renmimbi [US$791.08 million]
of which 61%
Pengxin International Mining Co Ltd
(14.79 billion Chinese Renmimbi [US$2.28 billion]
of which 85%
was Metal Products Trade), and
Jiangsu Azure Corp
(3.52 billion Chinese Renmimbi [US$543.12 million]
of which 49%
was Metal Logistics Distribution).
Wanbangde Pharmaceutical Holding Group Co Ltd reported sales of 15.79 billion Chinese Renmimbi (US$2.44 billion)
December of 2019.
increase of 10.2%
versus 2018, when the company's sales were 14.34 billion Chinese Renmimbi.
Sales of Nonferrous Metal Trade saw an increase
6.8% in 2019, from
11.39 billion Chinese Renmimbi to 12.17 billion Chinese Renmimbi.
Not all segments of Wanbangde Pharmaceutical Holding Group Co Ltd experienced an increase in sales in 2019:
sales of Other Operating fell 35.8% to 9.97 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).